COVID-19 Hastalığı ve Allerjik/İmmünolojik Hastalıkların Takibi Üzerine Etkisi

Şeker, Elif Dilara; Pala, Ayşegül; Özdemir, Öner

doi:10.31832/smj.731345

Cited by 2 publications

(1 citation statement)

References 25 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients who have either disease can demonstrate upper airway symptoms. Obtaining a test result that is positive for COVID-19 cannot exclude allergic rhinitis [11].…”

Section: Introductionmentioning

confidence: 99%

How does allergic rhinitis impact the severity of COVID-19?: a case–control study

Güvey¹

2021

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Background Coronavirus disease 2019 (COVID-19) is a contagious disease whose symptoms and risk factors are newly described. Some allergic diseases, including asthma, have been defined as risk factors for a poor outcome in COVID-19. We aimed to investigate the role of another allergic disease—allergic rhinitis—in the severity of COVID-19. Methods This case–control study was conducted at Sakarya Educational and Research Hospital, Toyota Hospital and Yenikent State Hospital between March 18, 2020 and August 30, 2020. The study included a case group of 125 randomly selected patients who had been diagnosed with allergic rhinitis in advance of having COVID-19 and a control group of 125 patients without allergic rhinitis who were diagnosed with COVID-19. We evaluated all participants’ statuses regarding smoking, symptoms, and hospitalization, as well as the length of their hospitalization and the number of their comorbidities. Results There were no statistically significant differences between the two groups regarding percentage of asymptomatic patients ( p = 0.27), presence of smoking ( p = 0.068), hospitalization status ( p = 0.79), and hospitalization length ( p = 0.55). From each group, two patients needed care in an intensive care unit (ICU). One patient from the case group and two from the control group died due to COVID-19. Conclusion We found that allergic rhinitis did not affect the severity of COVID-19. However, we recommend that the literature be augmented with further studies on the COVID-19 prognosis of patients who have allergic rhinitis. Supplementary Information The online version contains supplementary material available at 10.1007/s00405-021-06836-z.

show abstract

“…Patients who have either disease can demonstrate upper airway symptoms. Obtaining a test result that is positive for COVID-19 cannot exclude allergic rhinitis [11].…”

Section: Introductionmentioning

confidence: 99%

How does allergic rhinitis impact the severity of COVID-19?: a case–control study

Güvey¹

2021

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

show abstract

Perspective Chapter: Management of Allergic Diseases during Pandemic

Özdemir¹,

Yılmaz²

2023

Allergic Disease - New Developments in Diagnosis and Therapy

View full text Add to dashboard Cite

Over the recent time period, pediatric allergy clinics across the world have markedly changed their practice because of the COVID-19 pandemic. Nowadays, clinics are not inclined to accept a patient demanding a new procedure / therapeutic modality during pandemic. All allergic diseases require continuous management and treatment, and their socioeconomic burden has been increasing worldwide. In this chapter, the aim is to focus on allergic diseases management during pandemic. During this time, patient follow-up, patient management, and diagnostic tests are real challenges. Limited face-to-face consultations and as much as use of telemedicine are currently seen as the major issues in the allergy practice. Face-to-face examination and treatment should be preferred only in vital situations. During COVID-19 pandemic, patient education, which is the most important step in the treatment of allergic diseases, has started to be done online. The prevailing opinion in the allergy community is that the treatment should not be interrupted, or dose reduction should not be made. According to the guidelines, it is appropriately recommended to carefully calculate the profit and loss of the treatment on a case-by-case basis.

show abstract

COVID-19 Hastalığı ve Allerjik/İmmünolojik Hastalıkların Takibi Üzerine Etkisi

Cited by 2 publications

References 25 publications

How does allergic rhinitis impact the severity of COVID-19?: a case–control study

How does allergic rhinitis impact the severity of COVID-19?: a case–control study

Perspective Chapter: Management of Allergic Diseases during Pandemic

Contact Info

Product

Resources

About